Legis Daily

LABEL Opioids Act

USA117th CongressHR-1026| House 
| Updated: 4/28/2021
Greg Stanton

Greg Stanton

Democratic Representative

Arizona

Cosponsors (8)
Tom O'Halleran (Democratic)Jefferson Van Drew (Republican)Kathy E. Manning (Democratic)Don Bacon (Republican)Jahana Hayes (Democratic)Josh Harder (Democratic)Pramila Jayapal (Democratic)Mary Gay Scanlon (Democratic)

Crime and Federal Government Surveillance Subcommittee, Health Subcommittee, Judiciary Committee, Energy and Commerce Committee

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Lessening Addiction By Enhancing Labeling Opioids Act of 2021 or the LABEL Opioids Act This bill requires prescription opioids to contain a warning label specifying that the opioids may cause dependence, addiction, and overdose. A registrant (e.g., a pharmacist) who dispenses an opioid in violation of the labeling requirement is subject to penalties.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline

Bill from Previous Congress

HR 116-2732
LABEL Opioids Act
Feb 11, 2021
Introduced in House
Feb 11, 2021
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Feb 12, 2021
Referred to the Subcommittee on Health.
Apr 28, 2021
Referred to the Subcommittee on Crime, Terrorism, and Homeland Security.
Jul 15, 2021

Latest Companion Bill Action

S 117-2353
Introduced in Senate
  • Bill from Previous Congress

    HR 116-2732
    LABEL Opioids Act


  • February 11, 2021
    Introduced in House


  • February 11, 2021
    Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.


  • February 12, 2021
    Referred to the Subcommittee on Health.


  • April 28, 2021
    Referred to the Subcommittee on Crime, Terrorism, and Homeland Security.


  • July 15, 2021

    Latest Companion Bill Action

    S 117-2353
    Introduced in Senate

Crime and Law Enforcement

Related Bills

  • S 117-2353: LABEL Opioids Act of 2021
Administrative law and regulatory proceduresConsumer affairsCriminal justice information and recordsDepartment of Health and Human ServicesDrug, alcohol, tobacco useDrug safety, medical device, and laboratory regulationDrug trafficking and controlled substancesHealth information and medical recordsPrescription drugs

LABEL Opioids Act

USA117th CongressHR-1026| House 
| Updated: 4/28/2021
Lessening Addiction By Enhancing Labeling Opioids Act of 2021 or the LABEL Opioids Act This bill requires prescription opioids to contain a warning label specifying that the opioids may cause dependence, addiction, and overdose. A registrant (e.g., a pharmacist) who dispenses an opioid in violation of the labeling requirement is subject to penalties.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline

Bill from Previous Congress

HR 116-2732
LABEL Opioids Act
Feb 11, 2021
Introduced in House
Feb 11, 2021
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Feb 12, 2021
Referred to the Subcommittee on Health.
Apr 28, 2021
Referred to the Subcommittee on Crime, Terrorism, and Homeland Security.
Jul 15, 2021

Latest Companion Bill Action

S 117-2353
Introduced in Senate
  • Bill from Previous Congress

    HR 116-2732
    LABEL Opioids Act


  • February 11, 2021
    Introduced in House


  • February 11, 2021
    Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.


  • February 12, 2021
    Referred to the Subcommittee on Health.


  • April 28, 2021
    Referred to the Subcommittee on Crime, Terrorism, and Homeland Security.


  • July 15, 2021

    Latest Companion Bill Action

    S 117-2353
    Introduced in Senate
Greg Stanton

Greg Stanton

Democratic Representative

Arizona

Cosponsors (8)
Tom O'Halleran (Democratic)Jefferson Van Drew (Republican)Kathy E. Manning (Democratic)Don Bacon (Republican)Jahana Hayes (Democratic)Josh Harder (Democratic)Pramila Jayapal (Democratic)Mary Gay Scanlon (Democratic)

Crime and Federal Government Surveillance Subcommittee, Health Subcommittee, Judiciary Committee, Energy and Commerce Committee

Crime and Law Enforcement

Related Bills

  • S 117-2353: LABEL Opioids Act of 2021
  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Administrative law and regulatory proceduresConsumer affairsCriminal justice information and recordsDepartment of Health and Human ServicesDrug, alcohol, tobacco useDrug safety, medical device, and laboratory regulationDrug trafficking and controlled substancesHealth information and medical recordsPrescription drugs